about
Thymoquinone attenuates tumor growth in ApcMin mice by interference with Wnt-signalingDuodenal adenoma surveillance in patients with familial adenomatous polyposisThe APC tumor suppressor is required for epithelial cell polarization and three-dimensional morphogenesisCyclooxygenase- and cytochrome P450-derived eicosanoids in strokePopulation pharmacokinetic model for cancer chemoprevention with sulindac in healthy subjectsRegression of Colonic Adenomas After Treatment With Sulindac in Familial Adenomatous Polyposis: A Case With a 2-Year Follow-up Without a Prophylactic Colectomy.Chemoprevention in patients with genetic risk of colorectal cancersFamilial colon cancer syndromes: an update of a rapidly evolving fieldPDE5 inhibitors enhance celecoxib killing in multiple tumor types.Sulindac, 3,3'-diindolylmethane and curcumin reduce carcinogenesis in the Pirc rat, an Apc-driven model of colon carcinogenesisCurcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy.Hereditary Colorectal Cancer: Genetics and ScreeningEpithelial turnover in duodenal familial adenomatous polyposis: A possible role for estrogen receptors?Sulindac sulfide selectively increases sensitivity of ABCC1 expressing tumor cells to doxorubicin and glutathione depletionUrsodeoxycholic acid counteracts celecoxib in reduction of duodenal polyps in patients with familial adenomatous polyposis: a multicentre, randomized controlled trial.Eviendep® reduces number and size of duodenal polyps in familial adenomatous polyposis patients with ileal pouch-anal anastomosisPreventive effects of low-dose aspirin on colorectal adenoma growth in patients with familial adenomatous polyposis: double-blind, randomized clinical trial.Thymoquinone chemosensitizes colon cancer cells through inhibition of NF-κB.Management strategies in Lynch syndrome and familial adenomatous polyposis: a national healthcare survey in Japan.Prophylactic colectomy: Rationale, indications, and approach.Practical opportunities to improve early detection and prevention of colorectal cancer (CRC) in members of high-risk families.Children's International Polyposis (CHIP) study: a randomized, double-blind, placebo-controlled study of celecoxib in children with familial adenomatous polyposis.Garcinol exhibits anti-proliferative activities by targeting microsomal prostaglandin E synthase-1 in human colon cancer cells.Chemoprevention of familial adenomatous polyposis.Chemoprevention of hereditary colon cancers: time for new strategies.Familial adenomatous polyposis in pediatrics: natural history, emerging surveillance and management protocols, chemopreventive strategies, and areas of ongoing debate.Ulcerative colitis with inflammatory polyposis in a teenage boy: a case reportCelecoxib affects estrogen sulfonation catalyzed by several human hepatic sulfotransferases, but does not stimulate 17-sulfonation in rat liver.Can supplementation of phytoestrogens/insoluble fibers help the management of duodenal polyps in familial adenomatous polyposis?Endogenous conversion of ω-6 to ω-3 polyunsaturated fatty acids in fat-1 mice attenuated intestinal polyposis by either inhibiting COX-2/β-catenin signaling or activating 15-PGDH/IL-18.
P2860
Q21245755-869977C9-9A5F-4506-A7EF-21CC6AE1CBC8Q26799039-8FFF56AE-9885-42D8-BF2C-00128DDABB3DQ28255263-736E1E0F-C9F8-4749-9AC7-EC7180377C6DQ28271874-34645FA9-2FC2-4B6D-B9CC-7105503319A7Q33998845-979937F8-4DB0-4B21-8FFB-8491527F4CE5Q34136314-8146F116-88FC-4E0C-8222-35B05282F0C7Q34170508-CDFE9C26-F48F-43D5-8B30-EC898984C16CQ34292368-51549C77-5AAF-4E99-853C-9621242B1AB0Q35430943-F85D078C-2085-4A34-9A83-B92445B18B6EQ35763386-73BEA064-3055-47E8-BB8E-D68B1CDFA8E3Q35876385-0A3DDEAD-C23F-452C-8259-699107C038F7Q36014675-2B490667-37D6-4440-BAE3-C4AA2422EF4AQ36682613-8CDDF009-81E2-4A67-9D29-DC7F5A00FC77Q36765399-458E0D8C-1BAB-4444-B57D-9ADC1EE4AB01Q37113520-83E87AFF-EDC4-437E-8D44-E4AE6D8A4699Q37162458-5B66D1B8-FEAB-48E7-A874-AEB305FD8393Q37231983-F893E65B-4EF1-4097-81D6-117365E8B77BQ37288226-7BD17008-C211-4E89-B974-B3E44457C09EQ37670683-6C202841-C157-4392-869C-540B50C3C00BQ38270672-37267469-6328-4EB4-B3D1-EEFFCD59210EQ38362344-A1A222B1-5961-4B4C-B908-CB8CD776041AQ38372935-AC44B1DE-0DA0-4F8B-9F63-8D937838B5C6Q38754376-9CE54788-E95C-43A8-A500-81E1909AB57EQ38809315-DFA67265-45EA-4013-B4E0-2DA53F642B29Q38812583-6398812C-B7F2-409A-85AD-446D6705A837Q38884242-B959AF71-5056-4066-B223-3C6BA8E5AF9DQ42176851-AC67AB95-A5C6-409D-9514-657B3ECB2B2CQ46359743-90CBD7CD-C849-4C8B-BA6A-4D995FE4A843Q51323679-264E7AB9-EA0C-458C-9A4F-289DE672B35AQ53181748-BE14E6D1-BD3F-4D8F-A8A2-CA0ED90BB19B
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Chemoprevention in familial adenomatous polyposis
@ast
Chemoprevention in familial adenomatous polyposis
@en
Chemoprevention in familial adenomatous polyposis
@nl
type
label
Chemoprevention in familial adenomatous polyposis
@ast
Chemoprevention in familial adenomatous polyposis
@en
Chemoprevention in familial adenomatous polyposis
@nl
prefLabel
Chemoprevention in familial adenomatous polyposis
@ast
Chemoprevention in familial adenomatous polyposis
@en
Chemoprevention in familial adenomatous polyposis
@nl
P2860
P1476
Chemoprevention in familial adenomatous polyposis
@en
P2093
Francis M. Giardiello
P2860
P304
P356
10.1016/J.BPG.2011.08.002
P407
P577
2011-08-01T00:00:00Z